BRPI0512049A - usos antivirais de complexos de ácido borìnico - Google Patents

usos antivirais de complexos de ácido borìnico

Info

Publication number
BRPI0512049A
BRPI0512049A BRPI0512049-7A BRPI0512049A BRPI0512049A BR PI0512049 A BRPI0512049 A BR PI0512049A BR PI0512049 A BRPI0512049 A BR PI0512049A BR PI0512049 A BRPI0512049 A BR PI0512049A
Authority
BR
Brazil
Prior art keywords
acid complexes
boronic acid
antiviral
antiviral uses
complexes
Prior art date
Application number
BRPI0512049-7A
Other languages
English (en)
Inventor
Carolyn Bellinger-Kawahara
Kirk R Maples
Jacob J Plattner
Original Assignee
Anacor Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anacor Pharmaceuticals Inc filed Critical Anacor Pharmaceuticals Inc
Publication of BRPI0512049A publication Critical patent/BRPI0512049A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

USOS ATIVIRAIS DE COMPLEXOS DE áCIDO BORìNICO São descritos composições e métodos de uso de complexos de ácido borínico, especialmente hidroxiquinolina, imidazol e derivados de ácido picolínico, como agentes antivirais bem como agentes terapêuticas para o tratamento de doenças causadas por vírus.
BRPI0512049-7A 2004-06-14 2005-06-14 usos antivirais de complexos de ácido borìnico BRPI0512049A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57941904P 2004-06-14 2004-06-14
PCT/US2005/020978 WO2006085932A2 (en) 2004-06-14 2005-06-14 Anti-viral uses of borinic acid complexes

Publications (1)

Publication Number Publication Date
BRPI0512049A true BRPI0512049A (pt) 2008-02-06

Family

ID=36623539

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0512049-7A BRPI0512049A (pt) 2004-06-14 2005-06-14 usos antivirais de complexos de ácido borìnico

Country Status (12)

Country Link
US (1) US7393856B2 (pt)
EP (1) EP1765360B1 (pt)
JP (1) JP2008502694A (pt)
AT (1) ATE447960T1 (pt)
BR (1) BRPI0512049A (pt)
CA (1) CA2570577A1 (pt)
DE (1) DE602005017626D1 (pt)
ES (1) ES2333244T3 (pt)
MX (1) MXPA06014417A (pt)
PT (1) PT1765360E (pt)
TW (1) TW200612967A (pt)
WO (1) WO2006085932A2 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070179296A1 (en) * 2005-12-28 2007-08-02 Anacor Pharmaceuticals, Inc. Process for manufacturing picolinate borinic esters
ME02188B (me) 2006-02-16 2016-02-20 Anacor Pharmaceuticals Inc Mali molekuli koji sadrže boron kao antiinflamatorni agensi
WO2010018836A2 (ja) * 2008-08-11 2010-02-18 独立行政法人科学技術振興機構 ポリグルタミン凝集阻害剤
US8980544B2 (en) 2012-11-27 2015-03-17 The Penn State Research Foundation Boronic and borinic acid compounds as inhibitors of sulfenic acid-containing proteins
US9585396B2 (en) 2013-01-30 2017-03-07 Agrofresh Inc. Volatile applications against pathogens
US9138001B2 (en) 2013-01-30 2015-09-22 Agrofresh Inc. Use of benzoxaboroles as volatile antimicrobial agents on meats, plants, or plant parts
US8669207B1 (en) 2013-01-30 2014-03-11 Dow Agrosciences, Llc. Compounds and compositions
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
KR101756785B1 (ko) * 2015-03-10 2017-07-12 한국화학연구원 4배위 유기 붕소 화합물의 제조방법
WO2017155879A1 (en) 2016-03-07 2017-09-14 Agrofresh Inc. Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
US10961261B2 (en) 2017-03-01 2021-03-30 Anacor Pharmaceuticals, Inc. Oxaborole analogs and uses thereof
TWI794742B (zh) * 2020-02-18 2023-03-01 美商基利科學股份有限公司 抗病毒化合物
EP4204012A1 (en) 2020-08-31 2023-07-05 Pfizer Inc. Methods of protecting rna

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001002424A2 (en) 1999-07-07 2001-01-11 Du Pont Pharmaceuticals Company Peptide boronic acid inhibitors of hepatitis c virus protease
JP2006511613A (ja) * 2002-12-18 2006-04-06 アナコア ファーマシューティカルズ インコーポレイテッド ボロン酸複合体を含む抗生物質および使用法

Also Published As

Publication number Publication date
DE602005017626D1 (de) 2009-12-24
ATE447960T1 (de) 2009-11-15
PT1765360E (pt) 2009-12-24
EP1765360A2 (en) 2007-03-28
JP2008502694A (ja) 2008-01-31
WO2006085932A3 (en) 2006-10-05
US20060019927A1 (en) 2006-01-26
EP1765360B1 (en) 2009-11-11
TW200612967A (en) 2006-05-01
MXPA06014417A (es) 2007-03-08
WO2006085932A2 (en) 2006-08-17
HK1102702A1 (en) 2007-11-30
ES2333244T3 (es) 2010-02-18
US7393856B2 (en) 2008-07-01
CA2570577A1 (en) 2006-08-17

Similar Documents

Publication Publication Date Title
BRPI0512108A (pt) antibióticos contendo complexos de ácido borìnico e métodos de uso
BRPI0512049A (pt) usos antivirais de complexos de ácido borìnico
CO6351786A2 (es) Inkibidores de la cinasa map p38
NO20060091L (no) Anvendelse av kondenserte heterocykliske forbindelser som SCCE-inhibitorer for behandling av hudproblemer eller kreft
BRPI0418251C1 (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo
CR20110230A (es) Inhibidores de las enzimas de proteina cinasa activadas por mitogeno p38
DE60319406D1 (de) Meso-substituierte porphyrine
BR0207811A (pt) Compostos de uréia aril e heteroaril substituìdos úteis no tratamento de doenças
DE602004017194D1 (de) Pyridylpyrrol-derivate als wirksame kinase-hemmer
EA200970595A1 (ru) Производные замещенных индазолов, активные в качестве ингибиторов киназ
CR10358A (es) Pirido[3,2-e] pirazinas, su uso como inhibidores de fosfodiesterasa 10, y procesos para prepararlos
EA201291310A1 (ru) Композиция ингибитора jak для местного применения
BR112015007231A2 (pt) derivados de pirroltriazinona como inibidores de pi3k
BR0317564A (pt) Compostos, composições e métodos para tratar doenças causadas por bactérias ou fungos
ATE514699T1 (de) Substituierte pyrrolopyrazolderivate als kinaseinhibitoren
DE602004024037D1 (de) Substituierte heterozyklen
UY28271A1 (es) Compuestos químicos
BRPI0615270A2 (pt) pirazol fundido como inibidores de p38 map cinase
MX2010010505A (es) Imidazoquinolinas y derivados de pirimidina como moduladores potentes de los procesos angiogenicos impulsados por el factor de crecimiento endotelial vascular (vegf).
BRPI0513513A (pt) composto ou um sal farmaceuticamente aceitável do mesmo, processo para preparar o mesmo, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, métodos para produzir um efeito inibitório de eg5 e um efeito anticáncer em um animal de sangue quente, e para tratar carcinomas em um animal de sangue quente
UY28366A1 (es) Compuestos químicos
NO20074780L (no) Heterocyklylamidsubstituerte imidazoler
BRPI0512025A (pt) usos antiparasìticos de complexos de ácido borìnico
UY29046A1 (es) Derivados de n-(1h-indolil)-1h-indol-2-carboxamidas, su preparación y su uso en terapia
NO20081195L (no) Imidazopyridinderivater som kannabinoidreceptorligander

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.